The function and appearance of patients are negatively impacted by periodontitis and gingivitis, which also have a direct impact on their oral health-related quality of life (OHRQoL). Periodontitis has been associated with several systemic problems, such as poor pregnancy outcomes, cardiovascular diseases, type 2 diabetes mellitus (DM), respiratory disorders, fatal pneumonia in hemodialysis patients, chronic renal disease, and metabolic syndrome. The present review study aimed to investigate the impact of periodontal disease on patients' quality of life. We searched for studies of patients with non-alcoholic fatty liver disease in the Medline, Pubmed, Embase, NCBI, and Cochrane databases. Analysis was performed on management choices, etiology, and incidence. As of right now, it is evident that gingival inflammation is brought on by dental plaque, a microbial biofilm, and that several systemic and oral variables affect the degree and intensity of the inflammation. Furthermore, the dental plaque biofilm and the host's immune-inflammatory response interact in a complex way, as plaque builds up more rapidly in inflamed gingival locations than in non-inflamed sites. It is important to remember that not every inflammatory site will progress to periodontitis. Gingivitis should still be treated with appropriate topical therapeutic intervention to prevent loss of attachment and periodontal tissue deterioration. In the future, objective analytical methods such as transcriptome characterization or epigenetic alteration classification may be used to diagnose gingival disorders.
